Evidence map›Paper›PMID 39513613›Full record

ArticleOncology reports2025

Compression force promotes glioblastoma progression through the Piezo1‑GDF15‑CTLA4 axis.

Ok-Hyeon Kim, Israt Jahan Tulip, Hana Kang, Eun Seo Chang, Hyun Jung Lee

Abstract read
In one paragraph

Article in Oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ok-Hyeon Kim *Department of Anatomy and Cell Biology, College of Medicine, Chung‑Ang University, Seoul 06974, Republic of Korea.
Israt Jahan Tulip *Department of Global Innovative Drugs, Graduate School of Chung‑Ang University, Seoul 06974, Republic of Korea.
Hana KangDepartment of Global Innovative Drugs, Graduate School of Chung‑Ang University, Seoul 06974, Republic of Korea.
Eun Seo ChangDepartment of Global Innovative Drugs, Graduate School of Chung‑Ang University, Seoul 06974, Republic of Korea.
Hyun Jung LeeDepartment of Anatomy and Cell Biology, College of Medicine, Chung‑Ang University, Seoul 06974, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioma, a type of brain tumor, is influenced by mechanical forces in its microenvironment that affect cancer progression. However, our understanding of the contribution of compression and its associated mechanisms remains limited. The objective of the present study was to create an environment in which human brain glioma H4 cells experience pressure and thereby investigate the compressive mechanosensors and signaling pathways. Subsequent time‑lapse imaging and wound healing assays confirmed that 12 h of compression significantly increased cell migration, thereby linking compression with enhanced cell motility. Compression upregulated the expression of Piezo1, a mechanosensitive ion channel, and growth differentiation factor 15 (GDF15), a TGF‑β superfamily member. Knockdown experiments targeting

Indexed as

Brain NeoplasmsCell MovementCTLA-4 AntigenDisease ProgressionGlioblastomaGrowth Differentiation Factor 15Ion ChannelsSignal TransductionTumor MicroenvironmentCell Line, TumorGene Expression Regulation, NeoplasticHumansMechanotransduction, CellularUp-RegulationCTLA-4 AntigenCTLA4 protein, humanGDF15 protein, humanGrowth Differentiation Factor 15Ion ChannelsPIEZO1 protein, humancompression forceCTLA4gliomagrowth differentiation factor 15mechanosensorPiezo1

Identifiers

PMID39513613
PMCPMC11541303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.